acc 21: 30-day results of the triscend study
Published 3 years ago • 460 plays • Length 8:59Download video MP4
Download video MP3
Similar videos
-
4:49
acc 22: results from a sub-study of the poise-3 trial | dr maura marcucci
-
15:17
acc 21: findings from the raft-af trial
-
9:29
acc 2021: findings from the rescue trial
-
4:03
real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from triclip bright
-
2:33
tct 2021: triscend ii: 6mo outcomes show tr reduction in majority of patients | dr susheel kodali
-
2:31
acc.24: the dedicate-dzhk6 trial
-
7:29
day 4 post-surgical recovery: ulna shortening osteotomy and tfcc repair and debridement
-
2:36
tricuspid regurgitation: symptoms, causes and treatment | animation
-
8:28
14 - transcatheter tricuspid valve replacement: the new tavr! -hemal gada, md, mba
-
12:00
triscend: 6-month outcomes of transfemoral tvr in patients with tricuspid regurgitation
-
16:13
acc 23 late-breaker discussion: the clear-outcomes trial
-
6:52
transcatheter tricuspid valve replacement
-
3:47
acc 23: tavr in low-risk aortic stenosis patients: 3-year results from the evolut low risk trial
-
5:54
acc 23: pulsed field ablation in persistent atrial fibrillation patients: the pulsed af trial
-
3:34
europcr 21: results from the early neo2 registry
-
6:41
acc.24: the tact2 trial
-
9:00
transfemoral tricuspid valve replacement in patients with tricuspid regurgitation-30-day results of
-
5:36
tct 2022: tvt registry: teer in pts with severe mr and cardiogenic shock | dr alkhouli
-
4:31
acc 2017: tavr for bicuspid versus tricuspid aortic valve stenosis - dr sung-han yoon
-
0:56
acc23 preview: what should you know about the biovasc trial?
-
5:54
europcr 2018: early clinical experience of navigate in transcatheter tricuspid valve replacement